Iperboreal Pharma Srl Report issue

For profit Phase 2 Phase 3
Founded: San Giovanni Teatino Italy (2003)

Organization Overview

First Clinical Trial
2004
NCT00922701
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Iperboreal Pharma | Iperboreal Pharma Srl

Active Ingredients

Drugs in Phase 3 Trials (3)

glucose (2 trials)

levocarnitine (carnitor) (7 trials)

xylitol (3 trials)

Drugs in Phase 2 Trials (1)

icodextrin (Extraneal) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Insulin Resistance (Phase 2)

Kidney Failure, Chronic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 4